These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3198174)

  • 1. Serum HDL-cholesterol & urinary cholesterol in nephrotic syndrome.
    Nayak SS; Bhaskaranand N; Baliga M; Venkatesh A; Rao PV; Aroor AR
    Indian J Med Res; 1988 Aug; 88():150-5. PubMed ID: 3198174
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO; Agbedana EO; Kadiri S; Taylor GO
    Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A and high density lipoprotein cholesterol in childhood nephrotic syndrome.
    Agbedana EO; Taylor GO; Folami AO
    East Afr Med J; 1990 Apr; 67(4):279-85. PubMed ID: 2364904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)].
    Gomikawa S; Inagaki O; Mori H; Inoue S; Takamitsu Y; Fujita Y
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):239-46. PubMed ID: 8501853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid disturbances in the nephrotic syndrome].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2003; 60(11):758-61. PubMed ID: 15058052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipids and lipoprotein-cholesterol distribution in nephrotic syndrome patients during short term high dose steroid treatment.
    Arije A; Erasmus RT; Anjorin SA
    Cent Afr J Med; 1993 Oct; 39(10):211-5. PubMed ID: 8020077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
    El-Melegy NT; Mohamed NA; Sayed MM
    Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [alpha-Lipoprotein cholesterol content of the blood serum in nephrotic syndrome].
    Nikiforova NV; Sokolovskaia IV; Riaposova IK; Poliantseva LR
    Ter Arkh; 1982; 54(7):57-61. PubMed ID: 7135225
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary oval fat body and fat cylinder count in nephrotic syndrome].
    Minetti L; Scatizzi A; Grossi C
    Arch Ital Urol Nefrol; 1969; 42(2):180-98. PubMed ID: 5400334
    [No Abstract]   [Full Text] [Related]  

  • 12. [About two cases of massive hypercholesterolemia].
    Perier C; Raby N; Atieh S; Granouillet R; Chamson A
    Ann Biol Clin (Paris); 2005; 63(2):217-9. PubMed ID: 15771981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
    Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of non-HDL fraction to oxidation in experimental nephrotic syndrome.
    Dirican M; Taş S; Sarandöl E; Tokullugil HA
    Kobe J Med Sci; 1998 Dec; 44(5-6):235-45. PubMed ID: 10401226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
    Antikainen M; Holmberg C; Taskinen MR
    Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol metabolism in glomerular cells: effect of lipoproteins from nephrotic patients.
    Wanner C; Krämer-Guth A; Nauck M; Quaschning T; Pavenstädt H; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):39-46. PubMed ID: 8676822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J; Bar-On H; Shafrir E
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity.
    Appel GB; Blum CB; Chien S; Kunis CL; Appel AS
    N Engl J Med; 1985 Jun; 312(24):1544-8. PubMed ID: 3858668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome.
    Prata MM; Nogueira AC; Pinto JR; Correia AM; Vicente O; Rodrigues MC; Miguel MJ
    Clin Nephrol; 1994 May; 41(5):277-83. PubMed ID: 8050207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK; Arora RC; Agarwal N; Garg RK; Arora S; Gurbaxani RK; Sharma D
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.